Insider · CIK 0001977231
Geoffrey S Dow
Files at SXTP (60 DEGREES PHARMACEUTICALS, INC.). First filing Nov 21, 2024, latest Jun 15, 2026.
In brief
Geoffrey S Dow files SEC Form 4 as CEO, president and director at SXTP (60 DEGREES PHARMACEUTICALS, INC.). Since Nov 21, 2024, Geoffrey S Dow has reported 5 open-market buys worth $126k and 0 open-market sells worth $0, the latest filed on Jun 15, 2026.
A track record needs three past buys with six months of prices behind them; Geoffrey S Dow has 2, so none is measured yet.
The newest scored trade: bought $10k of SXTP on Jun 12, 2026, filed Jun 15, 2026, scored 49 (moderate). In the last 12 months: 3 buys worth $30k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SXTP: 60 DEGREES PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 49Moderate | SXTPbuy 60 DEGREES PHARMACEUTICALS, INC. | $10k 7,350 shares | +44% | 0% from low-87% from high | |
| 51Moderate | SXTPbuy 60 DEGREES PHARMACEUTICALS, INC. | $7,759 9,670 shares | +19% | 0% from low-89% from high | |
| 49Moderate | SXTPbuy 60 DEGREES PHARMACEUTICALS, INC. | $12k 12,963 shares | +35% | +3% from low-91% from high | |
| 57Moderate | 60 DEGREES PHARMACEUTICALS, INC. | $90k 73,951 shares | +358% | - | |
| 35Weak | SXTPbuy 60 DEGREES PHARMACEUTICALS, INC. | $6,367 7,000 shares | +51% | - |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +7,350 | $1.38 | $10k | 24,131 | Jun 15, 2026 |
| Dec 15, 2025 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +9,670 | $0.80 | $7,759 | 59,618 | Dec 16, 2025 |
| Dec 10, 2025 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +9,350 | $0.95 | $8,886 | 46,335 | Dec 12, 2025 |
| Dec 11, 2025 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +3,613 | $0.92 | $3,318 | 49,948 | Dec 12, 2025 |
| Sep 12, 2025 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | AGrant or award Common Stock | +7,201 | $1.39 | $9,996 | 33,372 | Sep 15, 2025 |
| Jun 9, 2025 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | AGrant or award Common Stock | +4,376 | $2.99 | $13k | 26,171 | Jun 9, 2025 |
| Jan 2, 2025 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +525,000 | $0.00 | $0 | 525,000 | Jan 24, 2025 |
| Jan 17, 2025 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | AGrant or award Common Stock | +14,394 | $0.00 | $0 | 108,974 | Jan 21, 2025 |
| Dec 5, 2024 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +17,549 | $1.11 | $20k | 38,178 | Dec 9, 2024 |
| Dec 6, 2024 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +20,579 | $1.20 | $25k | 58,757 | Dec 9, 2024 |
| Dec 9, 2024 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +35,823 | $1.27 | $46k | 94,580 | Dec 9, 2024 |
| Nov 19, 2024 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +2,500 | $0.90 | $2,248 | 16,129 | Nov 21, 2024 |
| Nov 20, 2024 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +1,000 | $0.92 | $924 | 17,129 | Nov 21, 2024 |
| Nov 21, 2024 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +3,500 | $0.91 | $3,195 | 20,629 | Nov 21, 2024 |
Questions about Geoffrey S Dow
Answered from the filings on this page, as of the latest one.
Is Geoffrey S Dow buying or selling?
In the last 12 months Geoffrey S Dow reported 3 open-market buys worth $30k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $10k of SXTP on Jun 12, 2026. Grants, option exercises and tax withholding are not counted.
How did Geoffrey S Dow's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Geoffrey S Dow has 2.
Where does Geoffrey S Dow file Form 4?
Geoffrey S Dow has filed Form 4 at SXTP (60 DEGREES PHARMACEUTICALS, INC.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.